AbCellera Biologics (ABCL)
NASDAQ:ABCL
Holding ABCL?
Track your performance easily

AbCellera Biologics (ABCL) Balance Sheet

1,541 Followers

AbCellera Biologics Balance Sheet

AbCellera Biologics's total assets for Q2 2024 were $1.41B, a decrease of -3.46% from the previous quarter. ABCL total liabilities were $301.51M for the fiscal quarter, a -9.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 1.49B$ 1.54M$ 1.32B$ 1.01B$ 23.49M
Total Liabilities
$ 285.30M$ 307.63K$ 292.84M$ 175.03M$ 13.24M
Total Equity Gross Minority
$ 1.15B$ 1.23M$ 1.03B$ 830.51M$ 10.25M
Total Capitalization
$ 1.15B$ 1.23M$ 1.03B$ 830.51M$ 11.62M
Preferred Stock Equity
----$ 7.55M
Capital Lease Obligations
--$ 40.06M$ 4.39M$ 3.06M
Currency in USD

AbCellera Biologics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis